These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9435250)

  • 1. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity.
    Chowdhury PS; Viner JL; Beers R; Pastan I
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):669-74. PubMed ID: 9435250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of anti-mesothelin antibodies from a phage display library.
    Chowdhury PS; Chang K; Pastan I
    Mol Immunol; 1997 Jan; 34(1):9-20. PubMed ID: 9182872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cloned Fvs from a phage display library indicates that DNA immunization can mimic antibody response generated by cell immunizations.
    Chowdhury PS; Pastan I
    J Immunol Methods; 1999 Dec; 231(1-2):83-91. PubMed ID: 10648929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma.
    Hassan R; Viner JL; Wang QC; Margulies I; Kreitman RJ; Pastan I
    J Immunother; 2000; 23(4):473-9. PubMed ID: 10916757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display.
    Lorimer IA; Keppler-Hafkemeyer A; Beers RA; Pegram CN; Bigner DD; Pastan I
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14815-20. PubMed ID: 8962138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent disulfide-stabilized fragment variable immunotoxin directed against mesotheliomas and ovarian cancer.
    Bera TK; Williams-Gould J; Beers R; Chowdhury P; Pastan I
    Mol Cancer Ther; 2001 Dec; 1(2):79-84. PubMed ID: 12467225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel high-affinity human monoclonal antibody to mesothelin.
    Ho M; Feng M; Fisher RJ; Rader C; Pastan I
    Int J Cancer; 2011 May; 128(9):2020-30. PubMed ID: 20635390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Mesothelin Recombinant Immunotoxin Therapy for Colorectal Cancer.
    Cerise A; Bera TK; Liu X; Wei J; Pastan I
    Clin Colorectal Cancer; 2019 Sep; 18(3):192-199.e1. PubMed ID: 31345777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.
    Hollevoet K; Mason-Osann E; Müller F; Pastan I
    PLoS One; 2015; 10(3):e0122462. PubMed ID: 25803818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-specific cytotoxic activity of recombinant immunotoxin scFv(MUC1)-ETA on breast carcinoma cells and primary breast tumors.
    Singh R; Samant U; Hyland S; Chaudhari PR; Wels WS; Bandyopadhyay D
    Mol Cancer Ther; 2007 Feb; 6(2):562-9. PubMed ID: 17308054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesothelin: a new target for immunotherapy.
    Hassan R; Bera T; Pastan I
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3937-42. PubMed ID: 15217923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic activity of the recombinant anti-mesothelin immunotoxin, SS1(dsFv)PE38, towards tumor cell lines established from ascites of patients with peritoneal mesotheliomas.
    Li Q; Verschraegen CF; Mendoza J; Hassan R
    Anticancer Res; 2004; 24(3a):1327-35. PubMed ID: 15274292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity.
    Mazor R; Onda M; Park D; Addissie S; Xiang L; Zhang J; Hassan R; Pastan I
    Oncotarget; 2016 May; 7(21):29916-26. PubMed ID: 27167198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tumor-specific human single-chain Fv selected from an active specific immunotherapy phage display library.
    Hall BL; Boroughs J; Kobrin BJ
    Immunotechnology; 1998 Oct; 4(2):127-40. PubMed ID: 9853954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of new anti-CD30 scFvs from DNA-immunized mice by phage display and biologic activity of recombinant immunotoxins produced by fusion with truncated pseudomonas exotoxin.
    Rozemuller H; Chowdhury PS; Pastan I; Kreitman RJ
    Int J Cancer; 2001 Jun; 92(6):861-70. PubMed ID: 11351308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
    Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
    Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro.
    Hassan R; Lerner MR; Benbrook D; Lightfoot SA; Brackett DJ; Wang QC; Pastan I
    Clin Cancer Res; 2002 Nov; 8(11):3520-6. PubMed ID: 12429643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.
    Fan D; Yano S; Shinohara H; Solorzano C; Van Arsdall M; Bucana CD; Pathak S; Kruzel E; Herbst RS; Onn A; Roach JS; Onda M; Wang QC; Pastan I; Fidler IJ
    Mol Cancer Ther; 2002 Jun; 1(8):595-600. PubMed ID: 12479219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
    Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
    Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin.
    Kioi M; Seetharam S; Puri RK
    Mol Cancer Ther; 2008 Jun; 7(6):1579-87. PubMed ID: 18566228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.